Humana Statistics
Total Valuation
Humana has a market cap or net worth of $46.33 billion. The enterprise value is $52.77 billion.
Important Dates
The last earnings date was Friday, November 6, 2026, before market open.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | Dec 24, 2026 |
Share Statistics
Humana has 120.10 million shares outstanding. The number of shares has increased by 0.31% in one year.
| Current Share Class | 120.10M |
| Shares Outstanding | 120.10M |
| Shares Change (YoY) | +0.31% |
| Shares Change (QoQ) | +0.57% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 99.01% |
| Float | 119.86M |
Valuation Ratios
The trailing PE ratio is 37.52 and the forward PE ratio is 22.52. Humana's PEG ratio is 1.01.
| PE Ratio | 37.52 |
| Forward PE | 22.52 |
| PS Ratio | 0.30 |
| Forward PS | 0.27 |
| PB Ratio | 2.83 |
| P/TBV Ratio | 6.62 |
| P/FCF Ratio | 14.96 |
| P/OCF Ratio | 12.59 |
| PEG Ratio | 1.01 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 17.59, with an EV/FCF ratio of 17.02.
| EV / Earnings | 42.87 |
| EV / Sales | 0.35 |
| EV / EBITDA | 17.59 |
| EV / EBIT | 19.01 |
| EV / FCF | 17.02 |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.71.
| Current Ratio | 1.65 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | 4.14 |
| Debt / FCF | 4.26 |
| Interest Coverage | 3.73 |
Financial Efficiency
Return on equity (ROE) is 6.74% and return on invested capital (ROIC) is 6.34%.
| Return on Equity (ROE) | 6.74% |
| Return on Assets (ROA) | 3.28% |
| Return on Invested Capital (ROIC) | 6.34% |
| Return on Capital Employed (ROCE) | 8.45% |
| Weighted Average Cost of Capital (WACC) | 7.00% |
| Revenue Per Employee | $2.30M |
| Profits Per Employee | $18,580 |
| Employee Count | 67,060 |
| Asset Turnover | 2.88 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Humana has paid $424.00 million in taxes.
| Income Tax | 424.00M |
| Effective Tax Rate | 25.15% |
Stock Price Statistics
The stock price has increased by +64.79% in the last 52 weeks. The beta is 0.64, so Humana's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | +64.79% |
| 50-Day Moving Average | 410.39 |
| 200-Day Moving Average | 320.92 |
| Relative Strength Index (RSI) | 37.97 |
| Average Volume (20 Days) | 1,690,585 |
Short Selling Information
The latest short interest is 2.78 million, so 2.31% of the outstanding shares have been sold short.
| Short Interest | 2.78M |
| Short Previous Month | 2.79M |
| Short % of Shares Out | 2.31% |
| Short % of Float | 2.32% |
| Short Ratio (days to cover) | 1.78 |
Income Statement
In the last 12 months, Humana had revenue of $154.19 billion and earned $1.25 billion in profits. Earnings per share was $10.28.
| Revenue | 154.19B |
| Gross Profit | 20.06B |
| Operating Income | 2.81B |
| Pretax Income | 1.69B |
| Net Income | 1.25B |
| EBITDA | 3.04B |
| EBIT | 2.81B |
| Earnings Per Share (EPS) | $10.28 |
Full Income Statement Balance Sheet
The company has $25.11 billion in cash and $13.38 billion in debt, with a net cash position of -$6.44 billion or -$53.62 per share.
| Cash & Cash Equivalents | 25.11B |
| Total Debt | 13.38B |
| Net Cash | -6.44B |
| Net Cash Per Share | -$53.62 |
| Equity (Book Value) | 18.89B |
| Book Value Per Share | 156.74 |
| Working Capital | 15.56B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $3.73 billion and capital expenditures -$592.00 million, giving a free cash flow of $3.14 billion.
| Operating Cash Flow | 3.73B |
| Capital Expenditures | -592.00M |
| Depreciation & Amortization | n/a |
| Net Borrowing | 768.00M |
| Free Cash Flow | 3.14B |
| FCF Per Share | $26.14 |
Full Cash Flow Statement Margins
Gross margin is 13.01%, with operating and profit margins of 1.82% and 0.81%.
| Gross Margin | 13.01% |
| Operating Margin | 1.82% |
| Pretax Margin | 1.09% |
| Profit Margin | 0.81% |
| EBITDA Margin | 1.97% |
| EBIT Margin | 1.82% |
| FCF Margin | 2.04% |
Dividends & Yields
This stock pays an annual dividend of $3.54, which amounts to a dividend yield of 0.92%.
| Dividend Per Share | $3.54 |
| Dividend Yield | 0.92% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 34.43% |
| FCF Payout Ratio | 13.54% |
| Buyback Yield | -0.31% |
| Shareholder Yield | 0.60% |
| Earnings Yield | 2.67% |
| FCF Yield | 6.68% |
Dividend Details Analyst Forecast
The average price target for Humana is $504.17, which is 30.69% higher than the current price. The consensus rating is "Buy".
| Price Target | $504.17 |
| Price Target Difference | 30.69% |
| Analyst Consensus | Buy |
| Analyst Count | 26 |
| Revenue Growth Forecast (3Y) | 13.43% |
| EPS Growth Forecast (3Y) | 29.14% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Stock Splits
The last stock split was on August 1, 1991. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Aug 1, 1991 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |